Navigation Links
LifeNet Health and Salvin Dental Specialties Announce Partnership
Date:6/17/2010

VIRGINIA BEACH, Va., June 17 /PRNewswire/ -- Salvin Dental Specialties, Inc. and LifeNet Health are pleased to announce they have signed an exclusive agreement  to advance LifeNet Health's OraGraft™ allograft products in the dental market.

The two companies have been in partnership since 1995. The new agreement builds on the existing relationship between these two companies, which provides LifeNet Health with Salvin Dental's strong, nationally recognized marketing and sales resources, while LifeNet Health's industry-leading reputation and quality allograft products offer a great bone grafting solution for Salvin Dental customers. LifeNet Health will continue to provide educational and research support to the dental community as well as continual support to its current clients through direct distribution.

Salvin Dental was founded in 1981 and is a global leader in the dental implant industry for bone grafting, instrumentation, and equipment. LifeNet Health, founded in 1982, is the country's largest, independent, non-profit, full-service tissue bank.

Under the agreement, Salvin Dental will act as the exclusive U.S. representative for the promotion of OraGraft™ allograft tissue products in the dental industry along with LifeNet Health. Salvin Dental will increase awareness in the dental industry about the availability of allograft products, which may be particularly beneficial for implant bone grafting and sinus lift procedures.

LifeNet Health is responsible for allograft procurement, processing, and distribution. The company utilizes the latest research and processing techniques to assure the highest quality donor screening and follows strict standards regarding donor qualification, tissue processing, and quality system review. Since introducing Allowash® technology in 1995, LifeNet Health has distributed more than 2.4 million allograft products without incidence of disease transmission.  

Bob Salvin, Founder and CEO for Salvin Dental, said, "Because of LifeNet Health's world-class reputation for its stringent quality processes and Salvin Dental's understanding of the bone grafting needs of the dental industry, this partnership benefits the customers we serve."

Rony Thomas, LifeNet Health's President and CEO, stated, "We are committed to working with Salvin Dental to provide LifeNet Health's OraGraft™ allograft to the patients who need them, and we are proud to be a part of the comprehensive Salvin Dental product offering."

Salvin Dental Specialties, Inc. is dedicated to providing innovative products and exceeding customers' expectations for quality, value, and service every time they call. For additional information about Salvin Dental Specialties, Inc., visit www.salvin.com.

LifeNet Health helps save lives and restore health for thousands of patients each year. LifeNet Health is the world's most trusted provider of transplant solutions, from organ procurement to new innovations in bio-implant technologies and cellular therapies—a leader in the field of regenerative medicine while always honoring the donors and healthcare professionals that allow the healing process.  For additional information about LifeNet Health, visit www.lifenethealth.org.


'/>"/>
SOURCE LifeNet Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. LifeNet Health Announces First Bio-Implant with New Preservation Technology
2. New Publications Highlight LifeNet Healths Life Saving Work in Neurosurgery
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
5. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Tone Deafness Explained, from the Harvard Health Letter
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
10. ViroPharma to Present at Three Upcoming Healthcare Conferences
11. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
(Date:2/24/2017)... Wyoming , Feb. 24, 2017  Xynomic Pharmaceuticals, ... today announced that it has acquired exclusive worldwide ... potentially best-in-class innovative HDAC inhibitor targeting hematological and ... of 14 Phase 1 and 2 clinical trials ... Asia have already been completed, demonstrating ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... , ... IndustryArchive.Org . is announcing a new way for B2B Sellers ... only pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase ... reality that B2B buyers are controlling the sales process via the Internet and that ...
(Date:2/26/2017)... ... , ... ODH, Inc.™ announced today it will exhibit and speak at ... Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present ... population health management. , ODH will also have an exhibit booth where attendees may ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure ... a specific LRRK2 mutation, according to a study released today at the 1st ... of a link between pesticides and incidence of sporadic PD through occupational exposure. ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... its newly designed TaskMate Go. Core benefits and advantages built into the home ... a stylish, functional look and feel. Ability to gain the benefits embedded in ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the ... Market (ILTM) show in Cannes (France), XO Private has initiated a second print-run of ... book measures almost a metre across when open, weighs in at more than six ...
Breaking Medicine News(10 mins):